(Medicare Policy Initiative) FDA approvals matter: When a GLP-1 drug gains an FDA label for something like reducing heart attack risk (beyond weight loss), that opens up possible Medicare Part D coverage for that use
Additionally, the verified AI prediction models and biomarker panels are integrated into the hospital's information system, providing doctors with decision support
Zhou Z, Wu H, Yang R, Xu A, Zhang Q, Dong J, Qian C, Sun M
2018;21(1s):177s-191s
The need for customers to do research and consult doctors before taking supplements is nothing new, but the stakes can feel higher when it comes to weight and weight loss, already such a vulnerable topic for so many